A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats

The British Journal of Ophthalmology
A BhatwadekarA W Stitt

Abstract

Diabetic retinopathy is associated with accumulation of advanced glycation end products in the retinal microvasculature. LR-90 is an effective multistage inhibitor of advanced glycation with renoprotective and anti-inflammatory properties. To explore the role of LR-90 in the progression of experimental diabetic retinopathy. Streptozotocin-induced diabetic Sprague-Dawley rats were treated with LR-90 (50 mg/l in drinking water) for up to 32 weeks. At the end of the study, eyes were enucleated and subjected to trypsin digestion and staining with light green/haematoxylin. Acellular capillaries and pericytes were quantified in random fields using light microscopy. In the LR-90-treated diabetic animals, acellular capillary numbers were reduced to 1.63 (0.20) from 2.58 (0.49) (p<0.05) in diabetic controls. LR-90 treatment also restored the pericyte deficit from 18.12 (0.98) in diabetic rats to 24.19 (0.76) (p<0.001). These findings show that LR-90 can effectively inhibit important lesions of diabetic retinopathy. This agent has potential for preventing retinopathy in patients with diabetes.

Citations

Sep 13, 2011·Amino Acids·Ross Milne, Seymour Brownstein
May 26, 2011·Current Diabetes Reports·Lynn C ShawMaria B Grant
May 19, 2011·Current Diabetes Reports·Hongliang ZongAlan W Stitt
Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Alan W Stitt, Timothy M Curtis
Apr 27, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Mohd Imtiaz NawazMohammad Shamsul Ola
May 11, 2011·Immunotherapy·Wenbo ZhangRuth B Caldwell
Mar 13, 2014·Apoptosis : an International Journal on Programmed Cell Death·James L FigarolaSharad S Singhal
Jun 7, 2014·Progress in Retinal and Eye Research·Stylianos A KandarakisAthanasios G Papavassiliou
Aug 25, 2015·Progress in Retinal and Eye Research·Alan W StittNoemi Lois
Dec 3, 2008·Expert Opinion on Emerging Drugs·Quresh Mohamed, Tien Y Wong
Aug 28, 2015·Journal of the American Society of Nephrology : JASN·Andréa E M StinghenAgnès Boullier
Dec 17, 2015·Omics : a Journal of Integrative Biology·Akanksha Gupta, Sonika Bhatnagar
May 8, 2010·Clinical & Experimental Ophthalmology·Ahmed M Abu El-AsrarKarel Geboes
Mar 31, 2015·Experimental Eye Research·Ingeborg KlaassenReinier O Schlingemann
Aug 5, 2011·Journal of Cardiovascular Disease Research·Wenbo ZhangRuth B Caldwell
May 14, 2016·Expert Opinion on Drug Delivery·Jayabalan NirmalRupesh Agrawal
Oct 21, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Eleni BeliMaria B Grant
Jul 10, 2016·Glycoconjugate Journal·Danielle J Borg, Josephine M Forbes
Sep 29, 2018·Current Protein & Peptide Science·Nikhil Shri SahajpalSubheet Kumar Jain
Oct 28, 2015·Stem Cells·Ashay D BhatwadekarMaria B Grant
Oct 17, 2019·International Journal of Molecular Sciences·Dinali H FernandoChandana B Herath

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.